Abstract
Congenital mesoblastic nephroma (CMN) is the most common tumor of kidney in early infancy. We present here a case of antenatally detected right renal mass that was excised and reported cellular CMN. He developed recurrence while on adjuvant chemotherapy. We emphasize that the management of cellular CMN, especially adjunct chemotherapy, has not been standardized yet.
Highlights
Congenital mesoblastic nephroma (CMN) is mostly a benign tumor of kidney, with nephroureterectomy as a standard of care and usually excellent prognosis
With documented chemosensitivity of CMN, we propose the pendulum should be swung in favor of sarcoma-based chemotherapy
HPE showed tumor composed of round by spindled out cells present in sheet, entrapping adrenal gland, clear to eosinophilic cytoplasm, showing brisk mitosis and cystic degeneration, suggestive of cellular CMN (Fig.4)
Summary
Congenital mesoblastic nephroma (CMN) is mostly a benign tumor of kidney, with nephroureterectomy as a standard of care and usually excellent prognosis. The cellular or atypical CMN is potentially aggressive variant and is known for local recurrence and even distant metastasis. The post-natal computed tomography performed at 3 weeks of age revealed a 6.5 x 5.2 x 4.1 cm right renal mass with solid and cystic components and associated localized peri-renal collection (Fig.2).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.